Cash And Equivalent Изменить Дата
Alaunos Therapeutics USD 11.94M 6.37M 2023-09
Amgen USD 10.94B 23.8B 2023-12
Arrowhead Research USD 58.22M 44.78M 2023-12
AstraZeneca USD 4.87B 793M 2023-09
Bluebird Bio USD 165.35M 7.52M 2023-09
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
Heron Therapeutics USD 34.86M 21.4M 2023-09
Incyte USD 3.21B 13.85M 2023-12
Intrexon USD 10.08M 6.47M 2023-09
Ligand Pharmaceuticals USD 22.95M 3.68M 2023-12
MannKind USD 238.48M 155.46M 2023-12
Merck USD 8.6B 2.94B 2023-09
Peregrine Pharmaceuticals USD 31.42M 6.53M 2023-09
Rigel Pharmaceuticals USD 45.41M 3.4M 2023-09
Roche Holding CHF 3.72B 1.27B 2023-06
Thermo Fisher Scientific USD 8.08B 1.93B 2023-12
Veracyte USD 216.45M 13.99M 2023-12
Xencor USD 53.79M 1.06M 2023-12



Intrexon Денежные Средства И Эквиваленты - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.